Colizor – 1MIU

Description

Colizor – 1MIU is a powerful antibiotic formulation containing Colistimethate Sodium Injection IP 1 Million IU, designed to combat serious and life-threatening bacterial infections. This composition belongs to the polymyxin class of antibiotics, known for its effectiveness against multidrug-resistant Gram-negative bacteria, especially in critical care settings.

The active ingredient, Colistimethate Sodium, works by damaging the bacterial cell membrane, leading to the rapid elimination of harmful pathogens. It is often reserved for cases where conventional antibiotics fail, making it a crucial option in modern antimicrobial therapy.

This injection is supplied in a 20ML vial, ensuring precise dosing and safe administration under medical supervision. It is commonly used in hospitals, particularly in ICUs, for severe infections.

Key Benefits & Uses:

• Effective against multidrug-resistant bacterial infections
• Commonly used for pneumonia and ventilator-associated infections
• Treats urinary tract and bloodstream infections
• Targets pathogens like Pseudomonas aeruginosa and Acinetobacter baumannii
• Ideal for critical care and hospital use

Due to its high potency, Colizor – 1MIU should only be used under strict medical supervision. Patients may require regular monitoring, as side effects like kidney or neurological issues can occur if not properly managed.

Conclusion:

Colizor – 1MIU is a dependable and potent antibiotic solution for severe infections, offering targeted action where other treatments fall short. It plays a vital role in saving lives in critical healthcare scenarios.